Time efficiency and cost savings are major challenges
in drug discovery
and development. In this process, the hit-to-lead stage is expected
to improve efficiency because it primarily exploits the trial-and-error
approach of medicinal chemists. This study proposes a site identification
and next choice (SINCHO) protocol to improve the hit-to-lead efficiency.
This protocol selects an anchor atom and growth site pair, which is
desirable for a hit-to-lead strategy starting from a 3D complex structure.
We developed and fine-tuned the protocol using a training data set
and assessed it using a test data set of the preceding hit-to-lead
strategy. The protocol was tested for experimentally determined structures
and molecular dynamics (MD) ensembles. The protocol had a high prediction
accuracy for applying MD ensembles, owing to the consideration of
protein flexibility. The SINCHO protocol enables medicinal chemists
to visualize and modify functional groups in a hit-to-lead manner.